#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Epstein-Barr virus infection Arterial disorder Chronic lymphocytic leukaemia refractory Postprandial hypoglycaemia Prophylaxis against transplant rejection Neutropenia Meningococcal immunisation Fungal infection Extra-osseous Ewing's sarcoma Congenital pseudarthrosis Alport's syndrome Necrotising myositis Dementia Alzheimer's type Neurotrophic keratopathy Renal disorder More trials…

    Learn about Rare Diseases

    Lymphatic malformation – Basic Information Hyperoxaluria – Basic Information Lymphangiosarcoma – Trials in Disease Alexander disease – Treatment Hereditary ataxia – Basic Information Haemophagocytic lymphohistiocytosis – Life with Disease Lennox-Gastaut syndrome – Diagnostics Mucopolysaccharidosis Antithrombin III deficiency – Diagnostics Lymphatic malformation – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Allopurinol Sodium Iptacopan Trastuzumab Deruxtecan Mps-106 ARFOLITIXORIN Specific Nucleic Acid Sna-Her1 Vemurafenib Riluzole Vortioxetine Sertindole Oditrasertib Ferric Carboxymaltose Indocyanine Green Water For Injection ZINC GLUCONATE Rly-4008 Pomalidomide Desloratadine Potato Starch Enx-101 More therapies…

    Learn about Your Condition

    Immune-mediated renal disorder Peripheral artery stenosis Medication overuse headache Postpartum haemorrhage Peritoneal sarcoma Neuroblastoma Papilloma viral infection Eosinophilic gastritis Alcoholic liver disease Breast cancer metastatic Plasma cell leukaemia Pertussis White matter lesion Mitral valve incompetence Primary adrenal insufficiency More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Uniwersytecki Szpital Kliniczny Im.Fryderyka Chopina…

Uniwersytecki Szpital Kliniczny Im.Fryderyka Chopina W Rzeszowie

Ul. Fryderyka Szopena 2, Rzeszow, 35-055, Poland

Want to learn more about this study or check if you can participate? Contact us.

  • Study on the Effectiveness and Safety of Ruxolitinib Cream for Patients with Prurigo Nodularis

    Not recruiting

    3 1
    Investigated Drugs:
    • Ruxolitinib
    Belgium France Germany Italy The Netherlands Poland +1

  • Study on the Safety and Effectiveness of Deucravacitinib for Patients with Active Discoid and/or Subacute Cutaneous Lupus Erythematosus

    Not recruiting

    2 1
    Investigated Diseases:
    • Chronic cutaneous lupus erythematosus
    • Subacute cutaneous lupus erythematosus
    • Cutaneous lupus erythematosus
    Investigated Drugs:
    • Deucravacitinib
    France Germany Poland

  • Study on Baricitinib for Treating Children Aged 6 to 17 with Alopecia Areata

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Alopecia areata
    Investigated Drugs:
    • Baricitinib
    France Germany Hungary Poland Spain

  • Study of Belrestotug and Dostarlimab for Patients with Untreated Advanced Non-Small Cell Lung Cancer

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Non-small cell lung cancer
    Investigated Drugs:
    • Human Igg1 Kappa Monoclonal Antibody Against Tigit
    • Dostarlimab
    • Pembrolizumab
    Belgium Bulgaria Croatia Czechia Estonia Finland +14

  • Study on Nemolizumab for Children Aged 2-11 with Moderate-to-Severe Atopic Dermatitis Not Controlled by Topical Treatments

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Dermatitis atopic
    Investigated Drugs:
    • Nemolizumab
    Hungary Poland Spain
Previous Page
1 … 7 8 9

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!